Associated Papers
Approach of Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome-Related Skin Tumors.
Băicoianu-Nițescu LC et al.
Diagnostics (basel, Switzerland), 2022
A somatic mutation in MEN1 gene detected in periventricular nodular heterotopia tissue obtained from depth electrodes.
Montier L et al.
Epilepsia, 2019
Novel Mutations in Serbian MEN1 Patients: Genotype-phenotype Correlation.
Isailovic T et al.
Journal of Medical Biochemistry, 2019
Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O et al.
Journal of Endocrinological Investigation, 2009
Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.
Lourenço DM et al.
European Journal of Endocrinology, 2008
Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
Vierimaa O et al.
European Journal of Endocrinology, 2007
Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.
Howell VM et al.
The Journal of Molecular Diagnostics : Jmd, 2006
Characteristics of the Danish families with multiple endocrine neoplasia type 1.
Jäger AC et al.
Molecular and Cellular Endocrinology, 2006
Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention.
Lim LC et al.
Journal of Internal Medicine, 2006
Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.
Ellard S et al.
Clinical Endocrinology, 2005
Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations.
Ebeling T et al.
The Journal of Clinical Endocrinology and Metabolism, 2004
JunD-menin interaction regulates c-Jun-mediated AP-1 transactivation.
Ikeo Y et al.
Endocrine Journal, 2004
Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
Sakurai A et al.
Endocrine, 2004
Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type 1.
Oiwa A et al.
Endocrine Journal, 2002
Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.
Guo SS et al.
Molecular Endocrinology (baltimore, Md.), 2001
The MEN1 gene and associated diseases: an update.
Tsukada T et al.
Endocrine Pathology, 2001
Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.
Uchino S et al.
Cancer Research, 2000
Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma.
Nord B et al.
International Journal of Cancer, 2000
Criteria for mutation analysis in MEN 1-suspected patients: MEN 1 case-finding.
Roijers JF et al.
European Journal of Clinical Investigation, 2000
Characterization of the MEN1 gene product, menin, by site-specific polyclonal antibodies.
Ikeo Y et al.
Japanese Journal of Cancer Research : Gann, 1999
Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.
Teh BT et al.
The Journal of Clinical Endocrinology and Metabolism, 1998
Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1.
Sakurai A et al.
Journal of Human Genetics, 1998